British Columbia Investment Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

British Columbia Investment Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-182,067	Closed	-$2.36M	–	840
2021 Q2	$2.36M	Buy	182,067 +59,959	+49%	+$764K	0.01%	674
2021 Q1	$1.59M	Sell	122,108 -49,848	-29%	-$723K	0.01%	718
2020 Q4	$2.37M	Sell	171,956 -23,793	-12%	-$346K	0.02%	612
2020 Q3	$2.88M	Buy	195,749 +28,897	+17%	+$419K	0.02%	483
2020 Q2	$2.71M	Buy	+166,852	New	+$2.67M	0.03%	457

Other funds holding AUPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KPWS

Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

British Columbia Investment Management's AUPH Position: Q3 2021 in Review

British Columbia Investment Management sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2021, closing a stake of 182,067 shares — an estimated $2.36M sold.

British Columbia Investment Management first reported a position in AUPH in Q2 2020 and held it in 5 quarters. The position peaked at $2.88M in Q3 2020. 166 funds tracked by Wall St. Rank hold AUPH as of Q3 2021.

British Columbia Investment Management reported no remaining Aurinia Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
British Columbia Investment Management sold 182,067 Aurinia Pharmaceuticals shares in Q3 2021, an estimated $2.36M.
British Columbia Investment Management first reported a position in Aurinia Pharmaceuticals in Q2 2020 and held it in 5 quarters.
British Columbia Investment Management's Aurinia Pharmaceuticals position peaked at $2.88M in Q3 2020.
166 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2021.

Based on British Columbia Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.